Key facts
- Calidar’s last known valuation is $25.6M (Dec 2025).
- It has raised $3.3M across 1 recorded rounds; the latest was Seed Round ($271K) in Jan 2022.
- Calidar has filed 1 Form D with the SEC, most recently Jan 2022 ($271K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Calidar
Funding rounds
1 roundsAbout Calidar
Developer of 4D mammography technology designed to improve the precision of breast cancer detection. The company offers combined three-dimensional imaging and X-ray diffraction-based molecular tissue analysis through patented hardware, enabling healthcare providers and diagnostic centers to detect abnormalities with enhanced imaging detail and support clinical decision-making.
- Sector
- Healthcare
- HQ
- Research Triangle Park, NC, United States
- Founded
- 2022
- Employees
- 7
- Website
- calidar.com/
- Ownership
- Privately Held (backing)
Calidar doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Calidar shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Calidar in its N-PORT filings yet. We sweep new filings monthly.